BioNTech CEO says omicron-specific vaccine delayed | The Hill: Healthcare Policy

admin February 17, 2022

Pfizer-BioNTech has announced that the omicron-specific COVID-19 vaccine it has in development could be delayed by several weeks because of the unpredicted amount of time it is taking the company to gather data, Reuters reports. BioNTech...